Aglas-Leitner, F. T.
Juillard, P.
Juillard, A.
Byrne, S. N.
Hawke, S.
Grau, G. E.
Marsh-Wakefield, F.
Funding for this research was provided by:
Multiple Sclerosis Research Australia (17-0140)
Merck (MS700568_0030)
Article History
Received: 8 July 2022
Accepted: 17 November 2022
First Online: 27 November 2022
Competing interests
: Dr Hawke has received research funding, travel, and educational grants from Merck Healthcare Pty. Ltd., Macquarie Park, Australia, an affiliate of Merck KGaA. Other authors have no competing interests.